Cancer News
Got Colon Cancer, Get Milk?

EHRs Not Living Up to the Hype

Prostate Brachytherapy Has Good Long-term Outcomes

Solution to US Cancer Care 'Crisis' Is Less Cancer Care

CAR T-Cells in Leukemia: Expert Commentary
Optimal centralised cancer care can narrow rural vs urban gap

Australian government commitment needed to reduce cancer care inequalities

Adaptimmune announces interim results from pilot trial of its engineered NY-ESO T cells targeting synovial sarcoma

Two-faced gene: SIRT6 prevents some cancers but promotes sun-induced skin cancer

Simple test may predict surgical wound healing complications after removal of soft tissue sarcomas
Healthy Lifestyle May Boost Breast Cancer Survival

Medicare Subsidy Helps Breast Cancer Patients Afford Treatment

Parenthood May Push Cancer Patients to Seek More Treatment

Anesthetic During Breast-Removal Surgery May Reduce Long-Term Pain

High Cholesterol Tied to Prostate Cancer's Return in Study
UCLA Vice Chancellor for Research Elected to Institute of Medicine

UCLA Cancer Researcher Receives Prestigious Innovator Award for Developing New Ways to Use Blood Stem Cells to Attack Cancer

Leading-Edge Lung Cancer Treatment Advances with $1M Grant to UCLA Scientists

Melanoma Drug Combo Improves Patient Survival Rate, Decreases Risk of Harsh Side Effect

UCLA Scientists Discover Protein that Can Potentially Accelerate Recovery in Cancer Patients Following Radiation and Chemotherapy
Adjuvant capecitabine plus oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): 5-year follow-up of an open-label, randomised phase 3 trial

Oral rivaroxaban versus enoxaparin with vitamin K antagonist for the treatment of symptomatic venous thromboembolism in patients with cancer (EINSTEIN-DVT and EINSTEIN-PE): A pooled subgroup analysis of two randomised controlled trials

Phase I study of 30-minute infusion of carfilzomib as single agent or in combination with low-dose dexamethasone in patients with relapsed and/or refractory multiple myeloma

Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12

Exercise and risk of major cardiovascular events in adult survivors of childhood Hodgkin lymphoma: a report from the childhood cancer survivor study
Translate